| 1 |
30019944 | A Computational Study on the Blocking Ability of Selected Commercially Available Anticancer Drugs and Their Hypothetic Derivatives on the CCR5. | 2018 Jul |
1 |
| 2 |
26081316 | A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity. | 2015 Jun 18 |
4 |
| 3 |
22252820 | Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists. | 2012 Apr |
1 |
| 4 |
20377425 | Conserved determinants of enhanced CCR5 binding in the human immunodeficiency virus subtype D envelope third variable loop. | 2010 Apr |
2 |
| 5 |
20401525 | Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis. | 2010 May |
1 |
| 6 |
18209074 | Inhibition of HIV-1 infectivity through an innate mechanism involving naturally occurring IgM anti-leukocyte autoantibodies. | 2008 Feb 1 |
1 |
| 7 |
17607321 | Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry. | 2007 Oct |
1 |
| 8 |
12692222 | Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry. | 2003 May |
1 |
| 9 |
11734558 | Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication. | 2002 Feb 15 |
1 |
| 10 |
11782464 | Association of chemokine-mediated block to HIV entry with coreceptor internalization. | 2002 May 10 |
1 |
| 11 |
11700073 | Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding. | 2001 Nov 9 |
1 |
| 12 |
10779565 | A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. | 2000 May 9 |
1 |
| 13 |
10196311 | Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. | 1999 May |
1 |
| 14 |
10200301 | Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications. | 1999 Apr 13 |
1 |
| 15 |
9420225 | Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. | 1998 Jan |
1 |
| 16 |
9525683 | Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1. | 1998 Apr |
3 |
| 17 |
9289016 | Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. | 1997 Aug 12 |
1 |